-
AI, Machine Learning & Computational Biology2 weeks agoAI designs working molecular scissors that recognize and cut selected protein targets
Proteases are naturally occurring enzymes that break down proteins into peptides and even single amino acids. They are useful in medicine and industrial processes, where they...
-
AI, Machine Learning & Computational Biology2 weeks agoIambic CEO on taking an AI drug company public
Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug development evolving.
-
AI, Machine Learning & Computational Biology2 weeks ago13 AI drug discovery companies you should know about
Take a look at 13 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process. The post...
-
AI, Machine Learning & Computational Biology2 weeks agoGenentech documentary celebrates 50th anniversary of biotech
A scientist and a financier walk into a bar… It sounds like the setup to a joke, but in the case of molecular biologist […] The...
-
AI, Machine Learning & Computational Biology2 weeks agoAI in drug discovery & development: News watch, October 2026
Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
-
AI, Machine Learning & Computational Biology2 weeks agoNewly Identified Microexons Offer Clues to Autism Spectrum Disorder’s Genetic Roots
Hundreds of newly identified microexons seem to matter for autism and other neurological conditions, according to a Nature study. A machine learning model of their regulatory...
-
AI, Machine Learning & Computational Biology2 weeks agoIllumina Combines Multiomics Informatics Applications in New BioInsight Platform
Illumina is bringing its software, AI, and data offerings together in the new BioInsight platform, designed to help scientists analyze genomic and multiomic datasets. It will...
-
AI, Machine Learning & Computational Biology2 weeks agoIambic, an AI drug discovery specialist, banks $150M in an IPO
Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt...
-
AI, Machine Learning & Computational Biology2 weeks agoExperimental Arrowhead RNAi drug hints at Alzheimer’s benefit
In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.
-
AI, Machine Learning & Computational Biology2 weeks agoTumor Twins: Living Lab-Grown Cancer Copies Paired With AI Could Transform Breast Cancer Treatment
A new review in Cellular and Molecular Life Sciences proposes hybrid biological-digital tumor twins, coupling patient-derived organoids with computational models in closed feedback loops, as a...
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
STAT+: HHS moves to allow compounding of some unapproved peptides
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
